Listen to the 2021 BMW M5 Competition's exhaust. It's loud, mean and aces all around.
Listen to the 2021 BMW M5 Competition's exhaust. It's loud, mean and aces all around.
Aktia Bank PlcPress release17 May 2021 at 2.15 p.m. The special investment fund Impakti becomes part of Aktia's product portfolio On 30 April 2021, Aktia announced that it had acquired the wealth management operations of Taaleri. As a result of the arrangement, the special investment fund Taaleri Impakti becomes part of Aktia’s product portfolio. The objective of the fund is to impact society and the environment in a positive way by investing funds in the stock market, the interest rate markets and alternative investments either directly or through other funds. The Impakti fund invests in, among other things, wind and solar energy as well as projects promoting environmental protection and energy efficiency. The globally investing fund aims to mitigate the effects of climate change, air and marine pollution as well as poverty and over-indebtedness in the world without compromising the returns. “Merging Aktia’s and Taaleri’s wealth management operations brings significant added value to Aktia's customers in the form of good products and better quality services. The Impakti fund is a good example of this. Aktia has an ambitious goal of being Finland's best asset manager. I am fully committed to this and I believe that we will achieve this goal by adopting the best practices that both parties bring to the new entity”, says Perttu Purhonen, EVP, Director of Aktia Asset Management. Impakti is the first impact fund in Aktia’s product range. Sustainable investment is an important part of the business operations, that Aktia wants to continuously develop with new services and products. “The Impakti fund aims to maximise societal and environmental benefits and market returns in relation to the risk level of the fund. It is good to see how enthusiastically impact investment is being pursued at Aktia. At Aktia we have an excellent framework for further developing Impakti”, says Pekka Samuelsson, Portfolio Manager of the fund. Further information: Thomas Lindholm, Director, Investments & Savings, AktiaTel. + 358 50 347 5329, thomas.lindholm (at) aktia.fi Aktia is a Finnish asset manager, bank and life insurer that has been creating wealth and wellbeing from one generation to the next for 200 years. We serve our customers in digital channels everywhere and face-to-face in our offices in the Helsinki, Turku, Tampere, Vaasa and Oulu regions. Our award-winning asset management business sells investment funds internationally. We employ approximately 930 people around Finland. Aktia's assets under management (AuM) on 31 December 2020 amounted to EUR 10.4 billion, and the balance sheet total was EUR 10.6 billion. Aktia's shares are listed on Nasdaq Helsinki Ltd (AKTIA). aktia.com.
ADC Therapeutics SA (NYSE: ADCT), a commercial-stage biotechnology company leading the development of novel antibody drug conjugates (ADCs) to treat hematological malignancies and solid tumors, today announced the receipt of the $50 million second tranche under its convertible credit facility with Deerfield Partners, L.P. and certain of its affiliates (collectively, Deerfield). Under the terms of the Facility Agreement dated April 24, 2020, Deerfield agreed to provide to the Company up to $115 million in financing consisting of two separate tranches. The first $65 million was received upon completion of the Company’s initial public offering in May 2020, and the second tranche of $50 million has now been received following the recent U.S. Food and Drug Administration (FDA) accelerated approval of ZYNLONTA™ (loncastuximab tesirine-lpyl).
Holidaymakers from England, Scotland and Wales are now able to jet off for some early summer sun.
The "Soy Milk - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Dublin, May 17, 2021 (GLOBE NEWSWIRE) -- The "Green Packaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global green packaging market was worth US$ 232.8 Billion in 2020. Green packaging, or sustainable packaging, refers to the use of sustainable materials and manufacturing methods for the packaging of goods. It utilizes biodegradable and plant-based plastics along with recycled molded packaging and used polyethylene bags to produce various products. In comparison to the conventionally used synthetic packaging process, green packaging has a reduced carbon footprint, which helps to support human and ecological health in the long run. The process of green packaging further includes ways that limit the amount of waste and emissions generated in the manufacturing process.The growing awareness regarding environmental conservation and sustainable living is one of the key drivers of the market. This, coupled with stringent governmental regulations for environment protection and the industrial trend of incorporating renewably sourced materials in the manufacturing process, is also significantly catalyzing the market growth. In addition to this, various industries have started to include green packaging as a part of their Extended Producers Responsibility (EPR). For instance, healthcare and food & beverage companies are opting for eco-friendly packaging products such as paper, glass, metal and plastic that can be easily recycled. Moreover, an increasing number of initiatives implemented by governments of both developed and emerging nations to encourage the incorporation of green packaging across various industries is also projected to drive the market in the coming years. Other factors contributing to the market growth include increasing research and development (R&D) activities and technological advancements in the manufacturing of green packaging materials such as bio-based resins. Looking forward, the publisher expects the global green packaging market to exhibit moderate growth during 2021-2026.Report Coverage: Historical, Current and Future Market Trends Market Breakup by Packaging Type: Recycled Content PackagingPaperPlasticMetalGlassOthersReusable PackagingDrumPlastic ContainerOthersDegradable Packaging Market Breakup by End Use Industry: Food IndustryBeverage IndustryHealthcare IndustryPersonal Care IndustryOthers Market Breakup by Region: Asia PacificEuropeNorth AmericaMiddle East and AfricaLatin America Competitive Landscape:The report has also analysed the competitive landscape of the market with some of the key players being Amcor Limited, DuPont, Mondi Limited, Sealed Air Corporation, TetraPak International S.A, Ardagh Group Company, PlastiPak Holdings, Bemis Company, Uflex limited and ELOPAK AS, etc.Key Questions Answered in This Report: How has the global green packaging market performed so far and how will it perform in the coming years?What has been the impact of COVID-19 on the global green packaging industry?What are the key regional markets in the global green packaging industry?What is the breakup of the market based on the packaging type?What is the breakup of the market based on the end use industry?What are the various stages in the value chain of the global green packaging industry?What are the key driving factors and challenges in the global green packaging industry?What is the structure of the global green packaging industry and who are the key players?What is the degree of competition in the global green packaging industry?What are the profit margins in the green packaging industry? Key Topics Covered: 1 Preface2 Scope and Methodology 3 Executive Summary4 Introduction4.1 Overview4.2 Key Industry Trends5 Global Green Packaging Market5.1 Market Overview5.2 Market Performance5.3 Impact of COVID-195.4 Market Breakup by Packaging Type5.5 Market Breakup by End Use Industry 5.6 Market Breakup by Region5.7 Market Forecast6 Market Breakup by Packaging Type6.1 Recycled Content Packaging6.1.1 Market Trends6.1.2 Market Breakup by Type126.96.36.199 Paper188.8.131.52.1 Market Trends184.108.40.206.2 Market Forecast220.127.116.11 Plastic 18.104.22.168.1 Market Trends22.214.171.124.2 Market Forecast126.96.36.199 Metal188.8.131.52.1 Market Trends184.108.40.206.2 Market Forecast220.127.116.11 Glass 18.104.22.168.1 Market Trends22.214.171.124.2 Market Forecast126.96.36.199 Others188.8.131.52.1 Market Trends184.108.40.206.2 Market Forecast6.2.3 Market Forecast6.2 Reusable Packaging6.2.1 Market Trends6.2.2 Market Breakup by Type220.127.116.11 Drum18.104.22.168.1 Market Trends22.214.171.124.2 Market Forecast126.96.36.199 Plastic Container 188.8.131.52.1 Market Trends184.108.40.206.2 Market Forecast220.127.116.11 Others18.104.22.168.1 Market Trends22.214.171.124.2 Market Forecast6.2.3 Market Forecast6.3 Degradable Packaging 6.3.1 Market Trends6.3.2 Market Forecast 7 Market Breakup by End Use Industry7.1 Food Industry7.1.1 Market Trends7.1.2 Market Forecast7.2 Beverage Industry7.2.1 Market Trends7.2.2 Market Forecast7.3 Healthcare Industry7.3.1 Market Trends7.3.2 Market Forecast7.4 Personal Care Industry7.4.1 Market Trends7.4.2 Market Forecast7.5 Others7.5.1 Market Trends7.5.2 Market Forecast8 Market Breakup by Region8.1 Asia Pacific8.1.1 Market Trends8.1.2 Market Forecast8.2 Europe8.2.1 Market Trends8.2.2 Market Forecast8.3 North America8.3.1 Market Trends8.3.2 Market Forecast8.4 Middle East and Africa8.4.1 Market Trends8.4.2 Market Forecast8.5 Latin America8.5.1 Market Trends8.5.2 Market Forecast9 SWOT Analysis9.1 Overview9.2 Strengths9.3 Weaknesses9.4 Opportunities9.5 Threats10 Value Chain Analysis10.1 Overview10.2 Sourcing of Raw Material10.3 Manufacture of Packaging Material10.4 Manufacturing of Packaged Goods10.5 Logistics10.6 Distribution Channel11 Porters Five Forces Analysis11.1 Overview11.2 Bargaining Power of Buyers11.3 Bargaining Power of Suppliers11.4 Degree of Competition11.5 Threat of New Entrants11.6 Threat of Substitutes12 Price Analysis12.1 Key Price Indicators12.2 Price Structure12.3 Margin Analysis13 Competitive Landscape13.1 Market Structure13.2 Key Players13.3 Profiles of Key Players13.3.1 Amcor Limited13.3.2 DuPont 13.3.3 Mondi Limited13.3.4 Sealed Air Corporation13.3.5 TetraPak International S.A.13.3.6 Ardagh Group Co.13.3.7 PlastiPak Holdings, Inc.13.3.8 Bemis Company, Inc.13.3.9 Uflex limited13.3.10 ELOPAK AS For more information about this report visit https://www.researchandmarkets.com/r/1wp5y5 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Materion Corporation (NYSE:MTRN) continues to build on its 50-year legacy of supporting space exploration and observation by partnering with The Vera C. Rubin Observatory on a first-of-its-kind custom optical filter set to be used on the Legacy Survey of Space and Time Telescope (LSST) currently under construction in Chile.
Bare Metal Cloud Market Research Report by Service Type (Compute Services, Database Services, Managed Services, Networking Services, and Professional Services), by Organization Size (Large Enterprises and Small and Medium-Sized Enterprises), by Vertical - Global Forecast to 2025 - Cumulative Impact of COVID-19New York, May 17, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Bare Metal Cloud Market Research Report by Service Type, by Organization Size, by Vertical - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06073659/?utm_source=GNW Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.1. The Global Bare Metal Cloud Market is expected to grow from USD 4,395.36 Million in 2020 to USD 12,835.28 Million by the end of 2025.2. The Global Bare Metal Cloud Market is expected to grow from EUR 3,853.93 Million in 2020 to EUR 11,254.21 Million by the end of 2025.3. The Global Bare Metal Cloud Market is expected to grow from GBP 3,426.15 Million in 2020 to GBP 10,005.02 Million by the end of 2025.4. The Global Bare Metal Cloud Market is expected to grow from JPY 469,096.29 Million in 2020 to JPY 1,369,849.62 Million by the end of 2025.5. The Global Bare Metal Cloud Market is expected to grow from AUD 6,382.64 Million in 2020 to AUD 18,638.53 Million by the end of 2025.Market Segmentation & Coverage:This research report categorizes the Bare Metal Cloud to forecast the revenues and analyze the trends in each of the following sub-markets:Based on Service Type, the Bare Metal Cloud Market studied across Compute Services, Database Services, Managed Services, Networking Services, Professional Services, Security Services, and Storage Services. Based on Organization Size, the Bare Metal Cloud Market studied across Large Enterprises and Small and Medium-Sized Enterprises. Based on Vertical, the Bare Metal Cloud Market studied across Banking, Financial Services, and Insurance, Government, Healthcare and Life Sciences, IT and ITES, Manufacturing, Media and Entertainment, Retail and Consumer Goods, and Telecommunications. Based on Geography, the Bare Metal Cloud Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Bare Metal Cloud Market including Alibaba Cloud, AWS, Bigstep, Dell, Equinix, Google, Hpe, IBM, Internap, Joyent, Limestone Networks, Lumen, Media Temple, Microsoft, Oracle, Ovhcloud, Phoenixnap, Rackspace, Scaleway, and Zenlayer. Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Bare Metal Cloud Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developmentsThe report answers questions such as:1. What is the market size and forecast of the Global Bare Metal Cloud Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bare Metal Cloud Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bare Metal Cloud Market?4. What is the competitive strategic window for opportunities in the Global Bare Metal Cloud Market?5. What are the technology trends and regulatory frameworks in the Global Bare Metal Cloud Market?6. What are the modes and strategic moves considered suitable for entering the Global Bare Metal Cloud Market?Read the full report: https://www.reportlinker.com/p06073659/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
AT&T Inc. (NYSE:T) and Discovery, Inc. (NASDAQ: DISCA, DISCB, DISCK) today announced a definitive agreement to combine WarnerMedia's premium entertainment, sports and news assets with Discovery's leading nonfiction and international entertainment and sports businesses to create a premier, standalone global entertainment company.
On 4 May 2021, Pandora announced a share buy-back programme, cf. Company announcement no. 622. The share buyback programme is executed in accordance with Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation). The purpose of the programme is to reduce Pandora’s share capital and to meet obligations arising from company incentive programmes. Under the programme Pandora will buy back shares for an amount up to DKK 500 million in the period from 5 May 2021 to 13 August 2021 at latest, both days inclusive. The following transactions have been made under the programme: Number of sharesAverage purchase price, DKKTransaction value, DKKAccumulated, latest announcement32,000 24,251,71010 May 202110,000 774.047,740,36111 May 202113,000 753.139,790,65812 May 202113,000749.559,744,093Accumulated under the programme68,000 51,526,822 With the transactions stated above, Pandora owns a total of 386,785 treasury shares, corresponding to 0.39 % of the Company’s share capital. In accordance with Regulation (EU) No 596/2014, all transactions related to the share buyback programme are presented in detailed form in the spread sheet attached to this Company Announcement. ABOUT PANDORA Pandora designs, manufactures and markets hand-finished jewellery made from high-quality materials at affordable prices. Pandora jewellery is sold in more than 100 countries through more than 6,700 points of sale, including more than 2,600 concept stores. Headquartered in Copenhagen, Denmark, Pandora employs 26,000 people worldwide and crafts its jewellery at two LEED certified facilities in Thailand using mainly recycled silver and gold. The company plans to be carbon neutral by 2025 and has joined the Science Based Targets initiative to reduce emissions across its full value chain. Pandora is listed on the Nasdaq Copenhagen stock exchange and generated sales of DKK 19.0 billion (EUR 2.5 billion) in 2020. CONTACTFor more information, please contact: INVESTOR RELATIONS John Bäckman VP, Investor Relations, Tax & Treasury +45 5356 email@example.com Kristoffer Aas Malmgren Investor Relations Director +45 3050 1174 firstname.lastname@example.orgCORPORATE COMMUNICATIONSJohan MelchiorDirector External Relations+45 4060 email@example.com Attachments Pandora_Company Announcement_No_624 Appendix_Company_Announcement_No_624 Appendix_Company_Announcement_No_624
The "Heart Failure - Epidemiology Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.
The market rally remains tricky, but ASML and Google are in buy zones. Beware false leaders like Apple. Bitcoin broke below key support on fresh comments from Elon Musk.
David Zaslav will lead a new combination of WarnerMedia and Discovery, the latest example of consolidation in the media and entertainment industry as the rise of video streaming continues to upend the entire sector. Zaslav was named CEO of the new company Monday, part of a surprising move by AT&T and Discovery to pool their […]
Cyclone Tauktae is likely to be the strongest storm to hit the western state of Gujarat since 1998.
Less than a year after winning an NBA title, the Lakers will try to become the first seventh seed or lower in league history to win a league title.
After more than a decade of fighting, the Islamist militant group is still causing havoc in the north-east.
BARRIE, Ontario, May 17, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation and derivative products today announced its financial results for the three months ended March 31, 2021, a period of ongoing progress in establishing itself as an international pharmaceutical company, specializing in cannabis. First Quarter Overview “We commenced 2021 focused on establishing our presence as a pharmaceutical company while ramping up and significantly growing our international sales,” said Keith Strachan, President and Interim CEO, MediPharm. “We achieved several important milestones including initial sales of GMP-certified medical cannabis products in Germany under our long-term partnership agreement with STADA Arzneimittel AG, a market leader in consumer healthcare and generics, and our first medical cannabis exports to Peru. Demand signals for our MediPharm cannabis oils were strong across all distribution channels in Canada. We made strong progress actively managing our cost structure which led to a 30% expense reduction, and we remain focused on returning to profitability.” “Looking ahead, the foundation for sustainable, long-term growth in the multibillion-dollar global pharmaceutical, medical and wellness market is taking shape with exciting international and domestic sales agreements creating tangible momentum for future quarters. Our focus remains on execution.” Q1 2021 Key Highlights Established Global Pharmaceutical Strategy including the U.S. Highly regulated traditional and established pharmaceutical channels have no borders. During the first quarter, and into the balance of 2021, MediPharm expanded its licenses, global regulatory authorizations, and product fillings with health authorities to allow for future sales into these channels. These channels are focused on larger patient markets that lack a defined federal cannabis framework, including the United StatesPatient demand for cannabis as a medical solution has increased around the world. Research advancements and big pharmaceutical participation will fill this need with traditional pharmaceutical drugs. These pharmaceutical companies are MediPharm’s current and future customers Expansion Underway in Germany, Leveraging Australian GMP Platform Achieved first sales to STADA with additional medical cannabis products to launch in Q2 2021Strengthened position as a recognized global leader in medical cannabis production with approval by the Australian Therapeutic Goods Administration to export cannabis oil products to white-label partners in Germany, one of the world’s most heavily regulated markets Officially Entered Latin American Medical and Wellness Markets Delivered first shipments of premium, high-THC medical cannabis to Cann Farm Peru S.A.C., marking MediPharm’s official entry into Latin America with additional sales expected to follow to other countries in the region pending final import/export permits Extended Footprint to Nine Countries with Exports Expected to Ramp Up in 2021 Established an agreement with Malta-based Pharma MT to supply premium, GMP certified, finished dose cannabis oil for patients and with it, expanded global customer base for turn-key manufacturing and distribution services to nine countries with exports expected to ramp up this yearForged a three-year supply agreement for specially formulated CBD and THC cannabis oil products with Cannim Australia Pty Ltd., expanding committed global customer base Scales Canadian Presence with High-Demand New Products, Expanded Distribution Added to innovative, pharma-quality family of branded products with the retail introduction of CBD 100 Ultra Formula Oil, THC30 Plus Formula Oil and CBN1:2 Nighttime Formula, the Company’s first cannabinoid cannabinol (CBN) rich formula which sold out in Ontario in its first few weeks of salesIncreased new listings and products with the Ontario Cannabis Store and expanded distribution to new retailers as part of MediPharm’s goal of becoming a one-stop-shop for retailers and distributors across Canada Balance Sheet Stability Supports Strategic Execution Cash and cash equivalents totaled $42.1 million at March 31, 2021 and the cash balance outstanding under the convertible notes less than $3.9 million, providing balance sheet strength to support of the Company’s long-term growth strategy Cost Containment Achieved over $1.5 million in cost savings in Q1 due to resulting from actions taken in Q3 and Q4 2020 as well as ongoing company-wide cost reduction and disciplined cost containment measures implemented, on track to achieve $3.6 million in annualized cost savings Q1 Reflects Progress with International and Finished Product Sales Growth International sales increased $1.8 million over Q4 2020 to $2.1 million in Q1 2021Challenging operating conditions in domestic Canadian retail channels and reduced purchasing measures undertaken by the provincial inventory management, due to the pandemic, resulted in lower volumes and a $2.3 million, or 40% decrease in revenue from Q4 2020 to $3.4 million in Q1 2021In total, revenue was $5.5 million, a 9% decrease from Q4 2020, but with a stronger mix of revenue international which offset a decrease to Canadian domestic revenue Financial Results Summary Table Three-months endedThree-months ended March 31, 2021December 31, 2020September 30, 2020June 30, 2020March 31, 2020 $’000s$’000s$’000s$’000s$’000s Revenue5,4956,0584,94713,91811,089Gross profit(680)(24,720)(10,588)2,212(10,882)Gross margin %(12%)(408%)(214%)16%(98%)Net income/(loss) before tax(13,867)(30,874)(15,422)(3,775)(22,029)Adjusted EBITDA(6,159)(8,767)(7,262)(2,180)(5,657)Adjusted EBITDA margin %(112%)(145%)(147%)(16%)(51%) (1) Adjusted EBITDA is a non-IFRS measure. See Non-IFRS Measures section of this news release. Q1 FINANCIAL RESULTS COMMENTARY AND NEAR-TERM OUTLOOK “As expected, Q1 was a cross-over period to our future state as the preferred global cannabis API provider to medical and wellness markets,” said Greg Hunter, CFO. “As such, we were pleased to see a substantial increase in international volumes and revenue which helped to offset challenging operating conditions in domestic Canadian retail channels.” “As a multi-country operator, with unique pharmaceutical licences and high-demand formulations, we are making the investments necessary to drive future growth and expand our international sales while managing our cost base. To maximize opportunities and market share in Canada, we successfully expanded retail distribution and achieved several new listings for our recently launched formulations. Gross profit of ($0.68) million and gross margin of (12%) in Q1 2021 improved over Q4 2020 because Q4 2020 was impacted by write down of non-current deposits, increased depreciation expense and inventory write down to net realizable value. Q1 2021 margins were negative primarily due to lower production volumes and inventory sold during the quarter was being held at net realizable value. There were no write-downs in the first quarter of 2021Q1 2021 Adjusted EBITDA(1) of ($6.2 million) in Q1 2021 improved $2.6 million over Q4 2020 due to improved gross margin and reduced operational expensesNet loss of $0.07 per share also compares favourably with the past two quarters (Q4 2020 net loss of $0.21 per share, Q3 2020 net loss $0.11 per share) reflecting the absence of inventory adjustments, fixed asset impairments and restructuring expense, as well as tighter expense controls Going forward, the Company expects finished product sales to continue to improve and sales to international pharmaceutical, medical and wellness markets to build over time according to planned customer ramp up schedules. Management will remain disciplined in managing expenses and deploying the balance sheet while expanding the Company’s product portfolio and international sales agreements. Looking Ahead - Strategic Progress Update To become the dominant player in the emerging global pharmaceutical, medical and wellness cannabis market – which represents a more sustainable and profitable revenue - MediPharm has made significant headway on its key priorities and is now fundamentally better positioned than ever to establish itself as a leading global pharmaceutical company, specializing in cannabis. GMP Platform to Serve Pharmaceutical Industry - The Company is executing on its established platform, purpose built to pharmaceutical Good Manufacturing Practices specifications (achieved with the awards of GMP certifications for its Canadian and Australian operations in 2019 and 2020 respectively) to serve pharmaceutical customers in multiple countries as a manufacturer of Active Pharmaceutical Ingredients derived from cannabis and medicinal cannabis finished dose products. Licensing and Regulatory Progress - MediPharm has secured licences globally to pioneer multiple regulatory pathways and access new markets, and possibly up to 50 countries as cannabis legalization takes hold over time. Over the past three years, the Company has built an industry-leading and expanding portfolio of licenses – including a Cannabis Drug Licence from Health Canada in Q1 2021 that is required for the production of pharmaceutical prescription drugs with a Drug Identification Number. This supports the participation in IP-capable clinical trials and partnerships with other pharmaceutical companies. Growing International Sales - The Company expects international sales to accelerate as strong progress has been made with at least 30 sales agreements in place in nine countries. International revenues reflect sales to customers in only three countries thus far. European revenue, one of the fastest growing cannabis markets, saw first revenues in Q1 2021 with only two German partners. As stated in the past, the early years in international pharmaceutical contracts are lean, but sales will grow steadily through 2021 and expand exponentially over time. Canadian Market as an Incubator for Innovative Products - MediPharm continues to produce innovative formulations and brands for multiple customers globally, which is expected to support future revenue growth. The Company achieved strong progress with the launch of an initial suite of MediPharm branded formulations in various formats and delivery methods as an alternative to selling bulk-formulated oils. Cost Containment and Return to Profitability - The Company continues to focus on returning to profitability through building sustainable revenue growth led internationally and improving efficiency through new cost controls instilled by a new CFO. These will reduce capital expenditures, cut operating costs, and improve product and service margins. CEO Search The Company’s Board of Directors previously appointed a special committee to lead the search for a permanent CEO. Following its engagement with global search firm Korn Ferry, the search committee has identified several strong candidates and interviews are well underway. Q1 2021 FINANCIAL RESULTS CONFERENCE CALL MediPharm executive management team will host a conference call and audio webcast to discuss the results and outlook for the three-month period ended March 31, 2021 on Monday, May 17, 2021, at 8:30 a.m. eastern time. Audio Conference Call Dial in Details: Date:May 17, 2021Time:8:30 a.m. eastern timeDial In:Toll-free number: +1-833-502-0471 / International number: +1-236-714-2179Conference ID:5847315Audio Webcast:WEBCAST or https://ir.medipharmlabs.com/news-events in the Events sectionReplay:+1-800-585-8367/ International +1-416-621-4642 Conference ID: 5847315 until May 24, 2021 11:59 p.m. eastern time NON-IFRS MEASURES Adjusted EBITDA is not a recognized performance measure under IFRS, does not have a standardized meaning and therefore may not be comparable to similar measures presented by other issuers. Adjusted EBITDA is included as a supplemental disclosure because Management believes that such measurement provides a better assessment of the Company’s operations on a continuing basis by eliminating certain non-cash charges and charges or gains that are non-recurring. Adjusted EBITDA is defined as net loss excluding interest, taxes, depreciation and amortization expense, interest income and expense, finance fees, gain in revaluation of derivative liabilities, taxes, impairment losses on inventory, write down of deposits and share-based compensation. Adjusted EBITDA has limitations as an analytical tool as it does not include depreciation and amortization expense, interest income and expense, taxes, share-based compensation and transaction fees. Because of these limitations, Adjusted EBITDA should not be considered as the sole measure of the Company’s performance and should not be considered in isolation from, or as a substitute for, analysis of the Company’s results as reported under IFRS. The most directly comparable measure to Adjusted EBITDA calculated in accordance with IFRS is operating income (loss). The above is a reconciliation of the Company’s operating loss to Adjusted EBITDA. See “Reconciliation of non-IFRS measures” in the Company’s Management’s Discussion and Analysis for the period ended March 31, 2021 for additional information. About MediPharm Founded in 2015, MediPharm specializes in the production of purified, pharmaceutical-quality cannabis oil and concentrates and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms. MediPharm has invested in an expert, research-driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with five primary extraction lines for delivery of pure, trusted and precision-dosed cannabis products for its customers. Through its wholesale and white label platforms, MediPharm formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. As a global leader, MediPharm has completed commercial exports to Australia and has fully commercialized its wholly-owned Australian extraction facility. MediPharm Australia was established in 2017. For further information, please contact: Laura Lepore, VP, Investor Relations Telephone: +1 416.913.7425 ext. 1525Email: firstname.lastname@example.org Website: www.medipharmlabs.com CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION: This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate to, among other things, statements regarding: the Company establishing itself as an international pharmaceutical company; ramping up and significantly growing international sales; returning to profitability; strong demand signals for MediPharm cannabis oils; sustainable, long-term growth; sales momentum for future quarters; future sales into pharmaceutical channels, including into the United States; research advancements and big pharmaceutical participation in the cannabis industry; future pharmaceutical company customers; additional medical cannabis products launching in Q2 2021; additional sales following to other countries in Latin America; pending final import/export permits; exports ramping up in 2021; expanding global customer base; becoming a one-stop-shop for retailers and distributors across Canada; long-term growth strategy; achieving $3.6 million in annualized cost savings; making the investments necessary to drive future growth while managing all expenses; recent trends in finished product sales continuing; sales to international pharmaceutical, medical and wellness markets building over time and in accordance with planned ramp up schedules; expanding the Company’s product portfolio and international sales agreements; serving pharmaceutical customers in multiple countries; participation in IP-capable clinical trials and partnerships with other pharmaceutical companies; international sales accelerating; future revenue growth; returning to profitability; and building sustainable revenues from Canadian business. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; the inability of MediPharm to obtain adequate financing; the delay or failure to receive regulatory approvals; and other factors discussed in MediPharm’s filings, available on the SEDAR website at www.sedar.com. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, MediPharm assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change.
Dublin, May 17, 2021 (GLOBE NEWSWIRE) -- The "Packaging Machinery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global packaging machinery market reached a value of US$ 49.2 Billion in 2020. Packaging machinery refers to a device that is used for packing different products and components. It plays a significant role in facilitating the packaging of small sachets to big cartons as well as providing temper resistance and ensuring the safety of the products. Different types of packaging machines are utilized for sorting, counting and accumulating various items. Due to technological progress, packaging machines have become more advanced and include numerous process operations such as fabrication, filling, sealing, cleaning, combining, labeling, palletizing and overwrapping.Apart from extending the shelf-life of the contents and protecting them against external elements like biological contamination, degradation, physical damage, and counterfeiting, packaging is also utilized for enhancing the appearance of fast moving consumer goods (FMCG) such as over-the-counter pharmaceuticals, processed food and beverages, and cosmetics. Moreover, consumers nowadays prefer flexible, lightweight, easy-to-carry packages. This is further supported by changing lifestyles and hectic schedules which have led to an increase in the need for convenient packaging solutions, thereby driving the demand for modern packaging machinery across the globe. Besides this, the leading packaging machinery firms are engaging in merger and acquisitions (M&A) activities to expand and increase the efficiency of their existing production facilities. Looking forward, the publisher expects the global packaging machinery market to exhibit moderate growth during the next five years. This latest report provides a deep insight into the global packaging machinery market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global packaging machinery market in any manner Report Coverage: Historical, Current and Future Market Trends Market Breakup by Machine Type: Filling MachinesFFS (Form, Fill and Seal) MachinesCartoning MachinesPalletizing MachinesLabeling MachinesWrapping MachinesCleaning & Sterilizing MachinesOthers Market Breakup by Technology: General PackagingModified Atmosphere PackagingVacuum Packaging Market Breakup by End-Use: FoodBeveragesPharmaceutical and Personal CareChemicalsOthers Market Breakup by Region: North AmericaAsia PacificEuropeMiddle East and AfricaLatin America Competitive Landscape:The report has also analysed the competitive landscape of the market with some of the key players being Barry-Wehmiller Companies, GEA Group, Illinois Tool Works,Krones, Robert Bosch GmbH, Adelphi Packaging Machinery, Aetna Group, B&H Labelling Systems, Bosch Packaging Machinery, Bradman Lake Group, CKD Group, Coesia SpA, Fuji Machinery Company, Harland Machine Systems Ltd., etc.Key Questions Answered in This Report: How has the global packaging machinery market performed so far and how will it perform in the coming years?What are the key regional markets in the global packaging machinery industry?What has been the imapct of COVID-19 on the global packaging machinery market?What is the breakup of the market based on the machine type?What is the breakup of the market based on the technology?What is the breakup of the market based on the end-use?What are the various stages in the value chain of the global packaging machinery industry?What are the key driving factors and challenges in the global packaging machinery industry?What is the structure of the global packaging machinery industry and who are the key players?What is the degree of competition in the global packaging machinery industry?What are the profit margins in the global packaging machinery industry? Key Topics Covered: 1 Preface2 Scope and Methodology2.1 Objectives of the Study2.2 Stakeholders2.3 Data Sources2.3.1 Primary Sources2.3.2 Secondary Sources2.4 Market Estimation2.4.1 Bottom-Up Approach2.4.2 Top-Down Approach2.5 Forecasting Methodology3 Executive Summary4 Introduction4.1 Overview4.2 Key Industry Trends5 Global Packaging Machinery Market5.1 Market Overview5.2 Market Performance5.3 Impact of COVID-195.4 Market Breakup by Machine Type5.5 Market Breakup by Technology 5.6 Market Breakup by End-Use5.7 Market Breakup by Region5.8 Market Forecast6 Market Breakup by Machine Type6.1 Filling Machines6.1.1 Market Trends6.1.2 Market Forecast6.2 FFS (Form, Fill and Seal) Machines 6.2.1 Market Trends6.2.2 Market Forecast6.3 Cartoning Machines6.3.1 Market Trends6.3.2 Market Forecast6.4 Palletizing Machines6.4.1 Market Trends6.4.2 Market Forecast6.5 Labeling Machines6.5.1 Market Trends6.5.2 Market Forecast6.6 Wrapping Machines6.6.1 Market Trends6.6.2 Market Forecast6.7 Cleaning & Sterilizing Machines6.7.1 Market Trends6.7.2 Market Forecast6.8 Others6.8.1 Market Trends6.8.2 Market Forecast7 Market Breakup by Technology7.1 General Packaging 7.1.1 Market Trends7.1.2 Market Forecast7.2 Modified Atmosphere Packaging7.2.1 Market Trends7.2.2 Market Forecast7.3 Vacuum Packaging 7.3.1 Market Trends7.3.2 Market Forecast8 Market Breakup by End-Use8.1 Food8.1.1 Market Trends8.1.2 Market Forecast8.2 Beverages 8.2.1 Market Trends8.2.2 Market Forecast8.3 Pharmaceutical and Personal Care 8.3.1 Market Trends8.3.2 Market Forecast8.4 Chemicals 8.4.1 Market Trends8.4.2 Market Forecast8.5 Others8.5.1 Market Trends8.5.2 Market Forecast9 Market Breakup by Region9.1 North America9.1.1 Market Trends9.1.2 Market Forecast9.2 Asia Pacific9.2.1 Market Trends9.2.2 Market Forecast9.3 Europe9.3.1 Market Trends9.3.2 Market Forecast9.4 Middle East and Africa9.4.1 Market Trends9.4.2 Market Forecast9.5 Latin America9.5.1 Market Trends9.5.2 Market Forecast10 SWOT Analysis10.1 Overview10.2 Strengths10.3 Weaknesses10.4 Opportunities10.5 Threats11 Value Chain Analysis12 Porters Five Forces Analysis12.1 Overview12.2 Bargaining Power of Buyers12.3 Bargaining Power of Suppliers12.4 Degree of Competition12.5 Threat of New Entrants12.6 Threat of Substitutes13 Price Analysis14 Competitive Landscape14.1 Market Structure14.2 Key Players14.3 Profiles of Key Players14.3.1 Barry-Wehmiller Companies14.3.2 GEA Group14.3.3 Illinois Tool Works14.3.4 Krones14.3.5 Robert Bosch GmbH14.3.6 Adelphi Packaging Machinery14.3.7 Aetna Group14.3.8 B&H Labelling Systems14.3.9 Bosch Packaging Machinery14.3.10 Bradman Lake Group14.3.11 CKD Group14.3.12 Coesia SpA14.3.13 Fuji Machinery Company14.3.14 Harland Machine Systems Ltd.For more information about this report visit https://www.researchandmarkets.com/r/n35pvx CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Bitcoin Association, the Switzerland-based global industry organisation that works to advance business with the Bitcoin SV blockchain and BSV digital currency, today announces that the 4th Bitcoin SV Hackathon will commence on June 14, with a $100,000 USD (payable in BSV) prize pool staked for the winners. The competition will be run in partnership with leading enterprise blockchain research & development firm nChain, with sponsorship provided by digital currency conglomerate CoinGeek.
Goodbye the Duke of Hastings, hello the Duc de Sauveterre
Follow here for the latest updates